Literature DB >> 26666907

Acute Respiratory Distress Syndrome: A Rare Complication in Pediatric Diabetic Ketoacidosis.

Siddhnath Sudhanshu1, Ganesh Jevalikar2, Pravin K Das3, Pramod K Singh4, Eesh Bhatia1, Vijayalakshmi Bhatia5.   

Abstract

Cerebral edema (CE) and non cardiogenic pulmonary edema (acute respiratory distress syndrome, ARDS) are life-threatening complications of diabetic ketoacidosis (DKA). In contrast to CE complicating DKA, which is primarily reported in pediatric patients, ARDS is rarely described in this age group. Here, the authors present a child with DKA who developed both cerebral edema and ARDS during the course of her management. It is feasible that severe acidosis, hypotension, azotemia, hypoalbuminemia and the superimposed aggressive intravenous fluid administration were important risk factors for the development of cerebral edema and ARDS in the index patient. The report highlights the importance of early diagnosis and aggressive therapy in the management of ARDS, and summarizes the published literature on this rarely reported complication of pediatric DKA.

Entities:  

Keywords:  ARDS; Cerebral edema; DKA; Mannitol; Pediatric

Mesh:

Substances:

Year:  2015        PMID: 26666907     DOI: 10.1007/s12098-015-1961-6

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  11 in total

1.  Vascular dysfunction in hyperglycemia: is protein kinase C the culprit?

Authors:  David D Gutterman
Journal:  Circ Res       Date:  2002-01-11       Impact factor: 17.367

2.  Acute pulmonary edema in juvenile diabetic ketoacidosis.

Authors:  D S Holsclaw; B Torcato
Journal:  Pediatr Pulmonol       Date:  1997-12

3.  Adult respiratory distress syndrome in an adolescent with diabetic ketoacidosis.

Authors:  S Breidbart; L Singer; Y St Louis; P Saenger
Journal:  J Pediatr       Date:  1987-11       Impact factor: 4.406

4.  Noncardiogenic pulmonary edema associated with diabetic ketoacidosis.

Authors:  C Perez Rueda; I Obando Santaella; I Mongil Ruiz; E Fernandez Gomez; A Gonzalez de Castro
Journal:  J Pediatr       Date:  1988-07       Impact factor: 4.406

5.  Risk factors for cerebral edema in diabetic ketoacidosis in a developing country: role of fluid refractory shock.

Authors:  Lokesh Kumar Tiwari; Muralindharan Jayashree; Jayashree Muralindharan; Sunit Singhi
Journal:  Pediatr Crit Care Med       Date:  2012-03       Impact factor: 3.624

6.  The adult respiratory distress syndrome in association with diabetic keto-acidosis. A case report.

Authors:  J Botha; D J van Niekerk; D J Rossouw; R I Stewart
Journal:  S Afr Med J       Date:  1987-04-18

7.  Adult respiratory distress syndrome complicating severely uncontrolled diabetes mellitus: report of nine cases and a review of the literature.

Authors:  P Carroll; R Matz
Journal:  Diabetes Care       Date:  1982 Nov-Dec       Impact factor: 19.112

8.  Preventing a drop in effective plasma osmolality to minimize the likelihood of cerebral edema during treatment of children with diabetic ketoacidosis.

Authors:  Ewout J Hoorn; Ana P C P Carlotti; Leila A A Costa; Beth MacMahon; Gareth Bohn; Robert Zietse; Mitchell L Halperin; Desmond Bohn
Journal:  J Pediatr       Date:  2007-05       Impact factor: 4.406

9.  Interstitial pulmonary edema in children and adolescents with diabetic ketoacidosis.

Authors:  W H Hoffman; J P Locksmith; E M Burton; E Hobbs; G G Passmore; A L Pearson-Shaver; D A Deane; M Beaudreau; R W Bassali
Journal:  J Diabetes Complications       Date:  1998 Nov-Dec       Impact factor: 2.852

10.  Simultaneous acute cerebral and pulmonary edema complicating diabetic ketoacidosis.

Authors:  M C Young
Journal:  Diabetes Care       Date:  1995-09       Impact factor: 19.112

View more
  1 in total

1.  Factors associated with cerebral edema in children under 5 years of age admitted in an intensive care unit and their outcome.

Authors:  Shamin Islam; Monira Sarmin; Tahmeed Ahmed; Farzana Afroze; Mohammod Jobayer Chisti
Journal:  SAGE Open Med       Date:  2019-09-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.